EN CN


Target Based Assays

Return

Metabolic Pathways Targets

Metabolic pathways are fundamental to cellular function, providing the energy and building blocks necessary for growth, maintenance, and response to environmental changes. Dysregulation of metabolic enzymes and pathways is linked to a variety of diseases, including cancer, metabolic disorders, and neurodegenerative diseases. Targeting these pathways through drug discovery allows for the development of therapies that can correct metabolic imbalances or exploit metabolic vulnerabilities in diseased cells.

Assay Principle

ADP-Glo Assay: In this assay, kinases interact with their substrates in the presence of ATP, which donates a phosphate group and produces ADP as a byproduct. After a set reaction time, an ADP-Glo reagent is added to stop the reaction and deplete remaining ATP, ensuring that only newly generated ADP is measured. A detection reagent then converts ADP back to ATP, which reacts with luciferase to produce a chemiluminescent signal proportional to kinase activity. 

Fluorescence Intensity (FI) Assay for NADP(H): This assay uses NADH/NADPH as a hydrogen carrier in the presence of a dehydrogenase enzyme, where it cycles between reduced (NADH/NADPH) and oxidized (NAD/NADP) forms. Upon excitation at 340 nm, NADH/NADPH emits fluorescence at 460 nm, while oxidized NAD/NADP forms do not emit. Fluorescence intensity directly reflects the concentration of NADH/NADPH, indicating the enzymatic activity. 

Absorbance (Abs) Assay: In this method, the substrate undergoes hydrolysis by the enzyme, producing a detectable product with a specific absorption peak. The optical density (OD) value of this product is measured using a spectrophotometer, providing a quantitative measure of enzyme activity based on absorbance changes.

Protein Assay Table

TargetSynonymsCategoryReference CompoundAssay Format
PFKFB3IPFK2; PFK2KinaseAZ PFKFB3 26ADP-Glo
15-PGDHHPGD; PGDH1DehydrogenaseML148FI
LDHALDH1; LDHMDehydrogenaseLDH-IN-1FI
LDHBLDH-HDehydrogenaseLDH-IN-1FI
IDH1PICDDehydrogenase(R,R)-GSK321FI
IDH2ICD-MDehydrogenaseAGI-6780FI
IDH1[R132H]/Mutant DehydrogenaseIvosidenibFI
IDH2[R132C]/Mutant DehydrogenaseAGI-6780FI
IDH1[R100A]/Mutant DehydrogenaseIvosidenibFI
IDH1[R100Q]/Mutant DehydrogenaseIvosidenibFI
IDH1[G97D]/Mutant DehydrogenaseIvosidenibFI
IDH1[Y139D]/Mutant DehydrogenaseIvosidenibFI
AKR1C1DDH, DDH1Aldo-keto ReductaseAKR1C1-IN-1FI
AKR1C3PGFSAldo-keto ReductaseASP-9521FI
ALDH1A1ALDC, ALDH1Aldehyde DehydrogenaseKS100FI
ALDH1A2RALDH2Aldehyde DehydrogenaseKS100FI
ALDH2ALDMAldehyde DehydrogenaseCVT-10216FI
ALDH3A1ALDH3Aldehyde DehydrogenaseKS100FI
IMPDH1IMPD1Inosine Monophosphate DehydrogenaseAVN-944FI
IMPDH2IMPD2Inosine Monophosphate DehydrogenaseAVN-944FI
MTAPMSAPMethylthioadenosine PhosphorylaseMT-DADMe-ImmAFI
DHODHDHOdehaseDehydrogenaseBrequinarAbs
MGLLMAGLHydrolaseJZL195Abs

Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital